Reply to: letter to the editor "subcutaneous herceptin therapy"

J Clin Pharmacol. 2013 Dec;53(12):1343-4. doi: 10.1002/jcph.172. Epub 2013 Sep 21.

Authors

Chris Wynne¹, Vernon Harvey, Christian Schwabe, Devonie Waaka, Christine McIntyre, Beate Bittner

Affiliation

¹ Christchurch Clinical Studies, Christchurch, New Zealand.

PMID: 23996383
DOI: 10.1002/jcph.172

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Antineoplastic Agents / administration & dosage*
Breast Neoplasms / drug therapy*
Female
Humans
Male

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents